Journal article

SOX9 regulates ERBB signalling in pancreatic cancer development

Adrien Grimont, Andreia V Pinho, Mark J Cowley, Cecile Augereau, Amanda Mawson, Marc Giry-Laterriere, Geraldine Van den Steen, Nicola Waddell, Marina Pajic, Christine Sempoux, Jianmin Wu, Sean M Grimmond, Andrew V Biankin, Frederic P Lemaigre, Ilse Rooman, Patrick Jacquemin

Gut | BMJ PUBLISHING GROUP | Published : 2015

University of Melbourne Researchers

Grants

Awarded by HGSC-BCM: NHGRI


Awarded by CPRIT grant


Awarded by Cancer Institute NSW


Awarded by Cancer Research UK


Awarded by NATIONAL HUMAN GENOME RESEARCH INSTITUTE


Funding Acknowledgements

This work was supported by grants from the Cancer Institute NSW; National Health and Medical Research Council of Australia; Australian Government: Department of Innovation, Industry, Science, Research and Tertiary Education; Australian Cancer Research Foundation; Queensland Government; University of Queensland; Cancer Council NSW; Garvan Institute of Medical Research; Avner Nahmani Pancreatic Cancer Research Foundation; R.T. Hall Trust; Petre Foundation; Jane Hemstritch in memory of Philip Hemstritch; Gastroenterological Society of Australia; American Association for Cancer Research Landon Foundation-INNOVATOR Award; Royal Australasian College of Surgeons; Royal Australasian College of Physicians; Royal College of Pathologists of Australasia; HGSC-BCM: NHGRI U54 HG003273; CPRIT grant RP101353-P7 (Tumour Banking for Genomic Research and Clinical Translation Site 1); Fondation contre le Cancer (Belgium); Fonds de la Recherche Scientifique-FNRS (Belgium); Universite catholique de Louvain. AG was supported by a grant from EU FP7 (Marie Curie Initial Training Network BOLD) and a Televie fellowship. AVP and MJC are supported by early career fellowships from Cancer Institute NSW. CA holds a Televie fellowship, IR is a Future Research Fellow of the Cancer Institute NSW (10/FRL2-03) and PJ is a Research Associate of the Fonds de la Recherche Scientifique-FNRS.